Metformin as an adjunct in treatment of Pulmonary Tuberculosis in Non-Diabetic patients. Source: Virtual Congress 2021 – Advances in treatment and management of tuberculosis and nontuberculous mycobacterial disease Year: 2021
Statin use and the risk of tuberculosis: Data from 305,142 patients Source: International Congress 2016 – New insights into aspects of tuberculosis epidemiology Year: 2016
Predictors of hepatotoxicity among patients with tuberculosis treated with antituberculous medication Source: International Congress 2016 – Tuberculosis: the elderly, the diabetic, the unusual, and the severe Year: 2016
Tuberculosis in patients receiving treatment of TNF-alpha inhibitors Source: International Congress 2015 – Case series and clinical conundrums in TB Year: 2015
Pulmonary tuberculosis in the elderly: A series of 163 cases Source: International Congress 2014 – Tuberculosis: from epidemiology to therapy 1 Year: 2014
Tuberculosis and diabetes mellitus: Treatment outcomes using directly observed therapy (DOT) Source: International Congress 2015 – Management of TB: a patient focus Year: 2015
Plasma concentration of isoniazid and rifampin in new tuberculosis patients with and without diabetes mellitus Source: International Congress 2015 – Treatment of TB (MDR-TB): co-morbidities, adverse effects and outcomes Year: 2015
Impact of diabetes on the presenting features of tuberculosis patients Source: International Congress 2014 – Mycobacterium tuberculosis infection and disease: clinical epidemiology 2 Year: 2014
Selection of patients from Pulmonary Rehabilitation (PR) to Disease Management (DM) programmes Source: International Congress 2017 – Latest insights into the management of chronic lung diseases Year: 2017
Incidence of Chronic Thromboembolic Pulmonary Hypertension (CTEPH) at six months of a Pulmonary Embolism (PE). OSIRIS Study Source: International Congress 2017 – Prognostic factors and outcomes in pulmonary embolism Year: 2017
Factors associated with severity of pulmonary tuberculosis and mortality in TB patients with diabetes mellitus Source: International Congress 2014 – Mycobacterium tuberculosis infection and disease: clinical epidemiology 1 Year: 2014
Evaluation of a novel clinic for management of Chronic Thromboembolic Pulmonary Disease (CTED) and associated Pulmonary Hypertension (CTEPH). Source: International Congress 2017 – PAH and CTEPH Year: 2017
Population pharmacokinetics (PK) of riociguat in patients (pts) with renal and hepatic impairment Source: International Congress 2014 – Pulmonary hypertension: novel targets and drugs Year: 2014
Tuberculosis and venous thromboembolism:Clinical features and outcomes Source: International Congress 2014 – Mycobacterium tuberculosis infection and disease: clinical epidemiology 1 Year: 2014
Efficacy of moxifloxacin instead of ethambutol in the intensive phase of therapy in newly diagnosed pulmonary TB Source: International Congress 2016 – Treatment management options and costs: vitamin D, Matrix metalloproteinases (MMPs), nutrition, and human genetics Year: 2016
Treatment effectiveness of TB patients from different groups of population in Moscow Source: International Congress 2016 – Epidemiological insights into tuberculosis pathogenesis Year: 2016
Blood and urine IP-10 associate with active TB in HIV-infected patients Source: International Congress 2016 – Latent tuberculosis infection Year: 2016
Sildenafil in Patients with Severe Group 3 Pulmonary Hypertension Source: International Congress 2018 – Pulmonary hypertension in lung diseases and the role of the right ventricle Year: 2018
Diabetes mellitus and pulmonary tuberculosis – Portuguese retrospective cohort Source: International Congress 2015 – Epidemiology of TB: deaths, co-morbidities, migration and children Year: 2015
The lung surgery for HIV-positive patients Source: International Congress 2016 – Open problems in thoracic surgery Year: 2016